VYD-2311 is under clinical development by Invivyd and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Simaravibart is under clinical development by Contraria Biotech and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

The World Health Organisation (WHO) has issued advice following a surge in hMPV cases in China, with the disease also on the ...

It's hard to believe it's been five years since the start of COVID-19. This timeline serves as a reminder of those early days ...

Merck & Co.’s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...

Convenor of Alpha Hour, Pastor Elvis Agyemang, has dropped a prophecy about a pandemic in 2025. He gave a vivid description ...

It can take several weeks bounce back after a bout of COVID-19, but some people develop more persistent problems. The ...

Covid, measles and Disease X continue to worry scientists and doctors, and they've been named among the 11 most dangerous ...

An Infectious Disease Specialist recalls what we have learned after Covid was first identified five years ago.

Wen: The majority of people with diarrhea, vomiting and stomach cramps have viral gastroenteritis caused by the very ...